An observational study of survival in patients with chronic-phase chronic myeloid leukemia (CML-CP) after 1, 3, and 5 years of tyrosine kinase inhibitor (TKI) therapy (SIMPLICITY) Meeting Abstract
| Authors: | Michallet, M.; Cortes, J.; Gambacorti-Passerini, C.; Hehlmann, R.; Williams, L. A.; Goldberg, S. L.; Davis, C.; De Solda, F.; Sen, G. P.; Gajavelli, S.; Mauro, M. J. |
| Abstract Title: | An observational study of survival in patients with chronic-phase chronic myeloid leukemia (CML-CP) after 1, 3, and 5 years of tyrosine kinase inhibitor (TKI) therapy (SIMPLICITY) |
| Meeting Title: | 6th Annual Meeting of the Society of Hematologic Oncology (SOHO 2018) |
| Keywords: | survival; chronic myeloid leukemia; tyrosine kinase inhibitor; deaths |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 18 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Sep 12-15 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-09-01 |
| Start Page: | S229 |
| Language: | English |
| ACCESSION: | WOS:000444343400155 |
| DOI: | 10.1016/j.clml.2018.07.105 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CML-264 -- Source: Wos |
